Matthew W. Davis insider trades

Open-market stock purchases and sales by Matthew W. Davis, Chief Development Officer at Aquestive Therapeutics, Inc, from SEC Form 4 filings since Nov 10, 2025.

Recent trades

DateStockTradeValue
Mar 9, 2026AQST Aquestive Therapeutics, IncBought (not open market)—
Nov 10, 2025AQST Aquestive Therapeutics, IncBought (not open market)—

Companies traded

  • AQST Aquestive Therapeutics, Inc: other filings, last Mar 9, 2026

Get free alerts when Matthew W. Davis files a new trade →